10 likes | 128 Vues
Supplementary Figure 4S.1.2.3 presents the impact of NEO212 on U251 and U251TR cell lines treated with different concentrations of temozolomide (TMZ). The U251 cells were exposed to 20 mM NEO212 alongside TMZ at 20 mM, while U251TR cells were treated with 50 mM NEO212 and 50 mM TMZ. This figure illustrates the cellular responses, highlighting differences between the two cell lines and their sensitivity to the treatments, contributing important insights into the efficacy of NEO212 as a potential therapeutic agent.
E N D
Supplementary Figure 4S 1 2 3 A U251 TMZ 20 mM NEO212 20mM 1 2 3 B U251TR TMZ 50 mM NEO212 50mM